Bahian, Chela N.
HRN: 16-39-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2023
CO-AMOXICLAV 625MG (TAB)
12/30/2023
01/06/2024
PO
1 Tab
Bid
Thinly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes